5. Conclusion
We proposed a novel classification system of adenoids based on
appearance, and divided into three types: edematous type, common type,
and fibrous type. The results showed that AR was the risk factor for the
development of AH. Among the children with AR, adenoids are mostly
edematous type. Additionally, we found that leukotriene receptor
antagonist was an important drug for the treatment of AH. The
glucocorticoid was only useful in the edematous type. Therefore, for AH
patients with AR, patients with edematous type adenoids and/or patients
with increased eosinophils in blood routine choose nasal glucocorticoid
combined with leukotriene receptor antagonist is
appropriate. On the contrary, leukotriene
receptor antagonists alone can be selected to treat AH.